Despite Mankind Pharma's powerful debut in the stock market and impressive quarterly results of some companies like Apollo Tyres, the market closed flat at 61,761.33. On the other hand, the Nifty 50 ended on a muted note at 18,265.95. Stock market investors will be keenly waiting for the quarterly results of Larsen & Toubro, Godrej Consumer Products, Dr. Reddy's Laboratories, and others set to be released on Wednesday.
Other than these companies, Procter and Gambler Hygiene, Gokul Agro, Sagar Cement, Cera Sanitary, BMW Industries, Orchid Pharma, Kabra Extrusion, Venkys, Sagar Cement, Pricol, MAS Financial Services, HG Infra Engineering, Prism Johnson, Cera Sanitary, etc will also announce their results today.
A day ahead of its quarterly result announcement, shares of Larsen & Toubro closed marginally higher at ₹2373.80 apiece on Tuesday. The company's market capitalisation stood at ₹3,33,633.36 crore on Tuesday.
The company's share value has increased by 13.64 per cent YTD, and by 46.94 per cent in one year. The Indian conglomerate managed to beat the market estimate and report a 22 per cent rise in its net profit to ₹303.6 crore for the December quarter in FY 23. L&T reported a net profit of ₹248.8 crore in the year-ago period. Its revenue grew by 21.4 per cent annually to ₹2,048.6 crore in the third quarter of FY23.
Sanofi India's shares ended marginally lower at ₹5572.65 apiece on BSE on Tuesday. Company's market capitalisation stood at ₹12,833.81 crores yesterday.
Company's revenue from operations declined by 2.32 per cent YoY to ₹671.9 crore in Q3FY23 from ₹687.90 crore Q3FY22. The net profit of the company came in at ₹130.9 crore in Q3FY23, up by 44.80% YoY from ₹90.4 crore in Q3FY22.
Novartis India share closed 4.56 per cent higher at ₹624.80 apiece on BSE on Tuesday. The company's share value decreased by 7.00 per cent YTD and increased merely by 5.02 per cent in a year.
The company's net profit dipped to ₹7.61 crores in the December quarter of FY23. Novartis India's total income came in at ₹88.53 crores during the period ended December 31, 2022 against ₹108.39 crore during the same period a year ago.
Company shares closed 0.56 per cent lower at ₹2078.25 apiece on BSE on Tuesday. Its market capitalisation stood at ₹27,420.56 crore yesterday.
The company reported a 6.7 per cent decline in its net profit to ₹180.8 crore in the third quarter of FY23. The farm and construction equipment manufacturer, reported a net profit of ₹193.71 crore in the same period a year ago. Its consolidated revenue from operations stood at ₹2,291.35 crore in Q3FY23 as against ₹1,998.29 crore in the year-ago period.
Godrej Consumer Products' share price closed 0.80 per cent higher at ₹951.50 apiece on BSE on Tuesday. The company's market capitalisation stood at ₹97,310.20 crore yesterday. Its share value has increased by 6.50 per cent YTD and 25.66 per cent in the last one year.
Driven by strong growth volumes in India, Godrej Consumer Products Ltd reported better-than-expected numbers during the quarter that ended in December. Godrej's revenue increased by 9 per cent last year. The company reported a net profit of ₹458.46 crore in the last financial year. It reported India volume growth of 3 per cent.
Reflecting positive market sentiments towards the company's quarterly results, Dr Reddy's Laboratories' shares closed marginally higher at ₹4930.55 apiece on BSE on Tuesday. Boost in the healthcare sector resulted in the rise in Dr Reddy's share value by 16.35 per cent YTD and by 26.15 per cent in one year.
In the quarter that ended in December, Dr Reddy's Laboratories reported a whopping 77 per cent rise in its net profit to ₹1,247 crore. Its net profit stood at ₹706.5 crore in the December quarter of the last financial year. Its total revenue from operations increased by 27 per cent to ₹6770 crore as against ₹5319.7 crore in Q3FY22.
Catch all the Business News , Market News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.